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beginning to be understood. In Gram-negative
bacteria, the vast majority of carbohydrate moieties are found in lipopolysaccharides (LPS)/
lipooligosaccharides (LOS) or capsular polysaccharide (CPS). There are an increasing number
of reports describing the modification of bacterial proteins with N‑ or O‑linked glycan moieties
(Figure 1) (reviewed in [8,9]).
One of the main challenges in the study of glycomes is the complexity of carbohydrate structures. In mammals, carbohydrates are assembled
from a group of approximately ten common
monosaccharides. By contrast, the absolute number of potential monosaccharide building blocks
in bacteria is unknown. Bacteria can synthesize
pentose and heptose sugars not commonly found
in mammals, and this diverse array of glycans is
proving to be an analytical challenge. In addition,
carbohydrate complexity increases as monosaccharides are assembled into linear and branched
polymers based on the regiochemistry and stereochemistry (a or b) of the anomeric carbon in the
glycosidic bond. For example, it is estimated that,
for a hexasaccharide, all possible oligosaccharide
isomers would yield approximately 1012 structures [10] . In addition to the monosaccharide and
linkage diversity, a number of modifications to
the monosaccharide subunits can occur, including methylation, sulfation, phosphorylation and,
in some bacteria, the addition of amino acids
[11,12] . Finally, the method of display of the glycan,
by attachment to lipids or via N‑ and O‑linkage
to proteins, adds further complexity to the glycome. This complexity is compounded by the
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Carbohydrates constitute the most structurally
diverse class of natural products and can serve
many functions in cells and organisms [1] . In addition to their role in energy metabolism, carbohydrates are also found attached to proteins and
lipids, or as loosely associated polysaccharides on
the cell surface. Glycobiology encompasses the
determination of the structure and function of
complex carbohydrates (glycans). More recently,
there has been a shift within glycobiology towards
large-scale systematic studies of the entire complement of glycan structures within a given cell or
organism, refered to as the ‘glycome’. Glycomics,
therefore, is the study of the significance of glyco
conjugate assembly and expression in biological
systems. Since glycosylation involves a series of
metabolic events, some of the concepts in lipid
omics [2] and metabolomics [3] are common to
glycomics. As a field, glycomics has lagged behind
genomics and proteomics, owing to the inherent
difficulties in the isolation of glycans, the subsequent analysis of their structure and function
and the limited number of different analytical
techniques available for use in their study.
Surface polysaccharides represent the predominant structures on all bacterial cell surfaces, and
they are often important players in the interactions between pathogens, their hosts and the
environment. These structures can be involved
in the maintenance of surface charge, phase
variation and serum resistance. In bacteria, the
role of these glycan moieties in symbiosis, pathogenesis, biofilm formation, cell–cell interactions
and evasion of the immune response [4–7] is just
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With the comprehensive study and complete sequencing of the Haemophilus
influenzae genome in 1995 came the term ‘genomics’ and the beginning of the
‘omics’ era. Since this time, several analogous fields, such as transcriptomics and
proteomics, have emerged. While growth and advancement in these fields have
increased understanding of microbial virulence, the study of bacterial glycomes
is still in its infancy and little is known concerning their role in host–pathogen
interactions. Bacterial glycomics is challenging owing to the diversity of glycoconjugate molecules, vast array of unusual sugars and limited number of
analytical approaches available. However, recent advances in glycomics
technologies offer the potential for exploration and characterization of both the
structures and functions of components of bacterial glycomes in a systematic
manner. Such characterization is a prerequisite for discerning the role of bacterial
glycans in the interaction between host defences and bacterial virulence factors.
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Figure 1. Microbial glycome diversity. (A) The Gram-negative cell showing the various
components that constitute the glycome: (1) nucleotide-linked sugar precursors; (2) peptidoglycan;
(3) N-linked glycoproteins; (4) lipopolysaccharide/oligosaccharide; (5) extracellular polysaccharide;
(6) capsular polysaccharide; (7) O-linked protein glycosylation, FliC, Salmonella enterica (PDB: 1UCU);
(8) pilin Neisseria gonorhoeae (PDB: 2HIL). (B) The mycobacterial glycome in addition to possessing
nucleotide-linked sugar precursors and peptidoglycan the cell surface contains: (9) arabinogalactan,
(10) mycolic acids, (11) lipomannan and (12) lipoarabinomannan. (C) The Gram-positive cell
produces many of the same glycoconjugates as the Gram-negative cell, such as capsular
polysaccharide, extracellular polysaccharide and a thicker peptidoglycan layer but, in addition,
produces the cell surface components (13) teichoic and (14) lipoteichoic acids.
IM: Inner membrane; OM: Outer membrane.

nontemplate-driven nature of glycan biosynthesis.
Taking all these factors into consideration, the
analytical challenge to dissect these structures,
and assign biological function, is substantial.
In this review we provide an overview of bacterial glycomes and the analytical techniques
that are employed in their study. Owing to the
2

Future Microbiol. (2010) 5(2)

diversity in this field, it is not feasible to discuss
all the contributions made to bacterial glycomics; therefore, this review will focus on surveying the recent literature and describing select
techniques that can be applied to the analysis
of the bacterial glycome. We then focus upon
how this work has specifically contributed to
future science group
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For many years, glycoproteins were thought to be
expressed solely by eukaryotes and archaea, but it
is now evident that glycoproteins are found in all
domains of life. The first noneukaryotic glycoprotein was the surface layer protein (SLP) from
the archaean Halobacterium salinarum [13,14] .
More recently, research has demonstrated that
several medically relevant human pathogens also
modify their proteins with glycan moieties [15] .
In the last decade, protein N‑glycosylation (via
asparagine residues) has been identified in the
intestinal pathogen C. jejuni [16] , and O‑linked
protein glycosylation (via serine or threonine
residues) has been described in pathogens such
as Helicobacter pylori [17] , Pseudomonas aeru‑
ginosa [18,19] , Neisseria spp. [20,21] , Escherichia
coli [22,23] and Clostridium difficile [24] . Protein
glycosylation has been increasingly reported in
both Gram-positive and Gram-negative bacteria,
commonly including flagellins [9] , pilins [25–27] ,
fimbriae [28] , cell surface proteins (e.g., adhesins [29–31]) and structural proteins (e.g., SLPs of
Gram-positive bacteria [32]). Although the function of the glycan moiety of these proteins has yet
to be determined, there are a number of reports
describing a role in virulence, colonization and
macromolecular assembly [33–35] .
Two different mechanisms for protein glycosylation have been observed and are based on
the mechanism through which the glycans are
transferred to proteins. In the first mechanism,
the transfer of carbohydrates occurs directly from
nucleotide-activated sugars to acceptor proteins.
This mechanism is typical of O‑glycosylation
in eukaryotes, and flagellar glycosylation in
several bacterial species [9] . Alternatively, an
oligosaccharide can be preassembled on a polyisoprene carrier before being transferred en bloc
to protein acceptors by an oligosaccharyltransferase. This type of mechanism is found in the
N‑glycosylation pathways in eukaryotes, bacteria [36] and archaea, and O‑linked glycosylation
of pili in P. aeruginosa [27,37,38] and Neisseria species [21] . Of particular note, the N‑linked glycosylaton pathway of C. jejuni produces a conserved
heptasaccharide with the structure GalNAca1,4-GalNAc-a1,4-(Glc-b1,3)-GalNAc-a1,4GalNAc-a1,4-GalNAc-a1,3-Bac2,4diNAc-b1,
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Deciphering the bacterial glycome using
mass spectrometry
Mass spectrometry in bacterial
glycoprotein discovery

where Bac2,4diNAc is 2,4-diacetamido‑2,4,6trideoxyglucopyranose [39] and is assembled by
proteins encoded in the protein glycosylation
(pgl) locus [16] . This glycan is synthesized on a
polyisoprenyl carrier at the cytoplasmic face of
the inner membrane through the action of a
phosphoglycosyltransferase (PglC) and several
glycosyltransferases (PglA, PglH, PglI and PglJ).
The assembled oligosaccharide is then flipped to
the periplasm by the action of the membraneassociated flippase (PglK). Once in the periplasm,
the oligosaccharide is transferred to proteins
that possess the extended sequon Asp/Glu–X–
Asn–Y–Ser/Thr (where X and Y are any amino
acid except Pro) by the oligosaccharyltransferase
(PglB) [40,41] . The similarities between the Pgl
pathway in Campylobacter and the eukaryotic
N‑glycosylation machinery have resulted in an
explosion of research on this pathway, as the pathway serves as a simplified model for studying the
eukaryotic system. Additionally, it can be functionally transferred to E. coli [42] , where it shows
potential for applications in glycoengineering [43] .
Detection of bacterial glycoproteins is often
a challenging task owing to the diverse array
of monosaccharide building blocks available to
bacteria. Nevertheless, detecting novel bacterial
glycoproteins and predicting the structure of the
attached glycans is virtually impossible, and must
be deduced using a wide range of bioanalytical
techniques. These include high-performance liquid chromatography (HPLC) [44] , mass spectrometry (MS) [45–48] , nuclear magnetic resonance
(NMR) [49] , polyacrylamide gel electrophoresis
(PAGE) [50] and capillary electrophoresis (CE)
[51–53] . Typically studies commence with glycoprotein detection by 1D or 2D gel electrophoresis,
where aberrant protein migration is often the first
clue. Commercially available lectin-binding kits
or carbohydrate-reactive dyes are frequently used.
Putative glycoproteins are then typically isolated
and their initial characterization generally relies
heavily upon MS, exploiting so-called ‘top-down’
or ‘bottom-up’ techniques. An outline of these
approaches, as applied to bacterial glycoprotein
discovery and analysis, is presented in Figure 2. The
higher throughput study of the entire complement of glycoproteins within a bacterial cell is
an emerging field known as ‘glycoproteomics’, a
description of which is beyond the scope of this
article. Progress in bacterial glycoproteomics has
recently been reviewed [54] .
‘Bottom-up’ MS analyses of putative bacterial glycoproteins can be carried out on purified glycoprotein(s) or protein(s) separated by
gel electrophoresis. The protein is digested with
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our understanding of the role of the bacterial
glycome in the host–pathogen interactions of
Campylobacter jejuni.
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Figure 2. Mass spectrometry workflow for the identification and characterization of
individual bacterial glycoproteins. ‘Bottom-up’ analyses of glycoproteins at the peptide level: the
bottom-up method involves the tandem mass spectrometry (MS/MS) analysis of enzymatically
digested protein/glycoprotein. (A) The diverse and unusual bacterial glycans make the interpretation
of bacterial glycopeptide MS/MS data challenging. De novo peptide sequencing is often required for
identification of bacterial glycopeptides. (B) Mass spectrometers equipped with electron transfer
dissociation (ETD) or electron capture dissociation (ECD) can be used to determine individual sites of
glycan linkages in glyopeptides. Both ETD and ECD afford an alternative method of peptide
fragmentation to more widely used collision-induced dissociation, preserving delicate glycan
modifications; (B) shows a representative ETD spectrum of Clostridium botulinum glycopeptide. A
combination of these complementary techniques allows a comprehensive characterization of a
putative glycoprotein sequence. (C) Typical peptide sequence coverage obtained for FlaA protein from
MS/MS and ETD data. These data showed that glycan was attached through O-linkage, with seven
sites of modification (Ser126, Ser139, Ser142, Ser165, Ser171, Ser176 and Ser182). ‘Top-down’ MS
analyses of purified intact glycoproteins: the top-down approach uses mass spectrometry techniques
to analyze the intact protein. (D) An observed mass in excess of the mass expected based on the
translated genome sequence is often indicative of post-translational modification, such as
glycosylation. The MS-profile of an intact protein usually results in a broad envelope of multiply
charged protein ions in the MS spectrum, from which the reconstructed molecular mass profile can be
calculated. The data shown in (D) shows the observed masses of FlaA from C. botulinum Alberta,
with three distinct masses of 32297, 31879 and 31462 Da. Of note, each of the major intact mass
peaks was separated by a mass of 417 Da, which corresponds to the mass of the flagellin glycan.
MS/MS analysis of a single, multiply charged protein ion, can often yield information regarding the
masses of labile, protein-associated, glycan ions. Analysis of C. botulinum Alberta flagellins using this
method revealed at least two distinct marker ions of mass-to-charge ratio 512.3 and 418.2. By
adjusting the collision energy at the front end of the mass spectrometer, these glycan associated ions
can also be observed (known as front-end collision-induced dissociation) (E). Subsequently, MS/MS of
the observed glycan fragment ions can yield information about the glycan composition. For the FlaA
protein of C. botulinum, the spectrum of the glycan oxonium ion at mass-to-charge ratio 418 gave an
MS/MS spectrum with predominant peaks at 274, 240 and 181 Da. The fragmentation pattern of this
glycan moiety closely resembled that previously observed for pseudaminic acid or legionaminic acid,
with an additional unknown mass of 143 Da. Overall, these data showed the FlaA protein to be
modified with a pseudaminic acid-like sugar of 417 Da, at seven sites via O-linkage via serine residues.
The structure of this sugar was determined by nuclear magnetic resonance of a purified glycopeptide,
and shown to be a novel legionaminic acid derivative, 7-acetamido-5-( N-methyl-glutam-4-yl)-amino3,5,7,9-tetradeoxy-d-glycero -a-d-galacto -nonulosonic acid [13] .
Data represented uses Clostridium botulinum strain Alberta flagellin, FlaA, as a representative
glycoprotein [13].
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heptasaccharides, and expression comparisons
of glycopeptides between C. jejuni 11168 and
its pglD mutant [59] . This study reported the
first observation of heptasaccharides containing monoacetylated bacillosamine-modifying
C. jejuni glycoproteins [59] .
Identification of glycoproteins is the first challenge; the second is gathering structural information regarding the attached sugar. In many cases,
this requires release of the glycan from the protein, to allow detailed structural analyses of the
glycan using MS or NMR. Release of bacterial
glycans from proteins can be challenging – many
existing methods were developed for release and
study of eukaryotic glycans. These techniques
may not be applicable to bacterial proteins
because the carbohydrate–peptide linkages are
different and the enzymes capable of releasing
the carbohydrate moieties are rarely available.
However, a universal glycomics method was
used to address the challenges of glycan structural investigations. This method, based on the
combination of nonspecific proteolytic digestion
and permethylation, was applied as a complementary approach to study the diversity of
C. jejuni 11168 N‑linked sugars [61] . N‑glycome
analysis of C. jejuni 11168 allowed, for the first
time, detection of free heptasaccharide that were
unexpectedly produced by the N‑glycan pathway within the periplasm. The authors were able
to clearly distinguish between free glycan and
asparagine-linked glycan [61] .
Unambiguous structural assignment is most
readily obtained from NMR studies of purified sugars or short glycopeptides. In addition
to challenges in releasing glycans from bacterial
proteins, obtaining sufficient glycan material
from purified proteins is difficult. In attempts
to overcome this obstacle, focused metabolomics
studies have targeted intracellular nucleotideactivated glycan precursors in order to characterize glycan biosynthetic pathways, using both
MS and NMR. Such studies have been pivotal
in the structural analysis of C. jejuni proteinassociated glycans, and in functional studies of
the associated biosynthetic pathways [17,62–67] .
Such work is often a prerequisite for further
functional studies of the role of the glycoprotein
in virulence.
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a proteolytic enzyme, most commonly trypsin, and analyzed by tandem MS (MS/MS).
Consequently, strategies to rapidly identify and
evaluate glycopeptides are required. The use of
software tools for assignment of peptide fragmentation data are widely used as a matter of routine
(e.g., MASCOT™; Matrix Science, London,
UK). By contrast, the development and use of bioinformatics tools and databases for glycobiology
and glycomics research has been slow. Softwareassisted data analysis of bacterial glycopeptide tandem mass spectra is often hampered by a lack of
knowledge of the glycan produced by a particular
bacterium. Therefore, de novo glycopeptide analyses are necessary, despite being time consuming
and often a bottleneck in such studies. Additional
information obtained from ‘bottom-up’ studies
includes linkage site information and glycan
sequence information [55] . Observation of glycan
MS/MS fragmentation patterns can potentially
provide clues as to the glycan structure.
‘Top-down’ MS permits the study of the
intact protein, rather than the peptides generated from proteolytic digestion of the protein.
Recently, a top-down MS approach was applied
to expedite the identification of unusual bacterial
glycoprotein-associated ions (so-called ‘oxonium’
ions) [56] . The selectivity and specificity of this
approach was exploited for the identification of
the unusual glycan modification of flagellin from
protein H. pylori [56] . Studies of Clostridium botu‑
linum strains also used this approach as a higherthroughput method of characterizing flagellin
from a wide range of C. botulinum isolates, and
showed potential for flagellin glycan-associated
marker ions in strain differentiation [12,57] .
Newer strategies are currently being developed
to specifically enrich glycoproteins or peptides
from bacteria. Some of these approaches are
being adapted from methods developed for the
study of eukaryotic glycans [58] . For example,
hydrazide capture of N‑linked glycoproteins,
lectin affinity purification and ion-pairing normal phase liquid chromatography (IP‑NPLC)
are being applied to prokaryotic glycoprotein discovery, and are increasing the study of
glycoproteomics [59,60] .
Of particular interest, a recent study used
IP‑NPLC to resolve glycosylated peptides from
a tryptic digest of C. jejuni 11168 periplasmic
proteins. The method used acids as ion-pairing
reagents in normal-phase chromatography to
increase the hydrophobicity differences between
nonglycopeptides and glycopeptides. This permitted the reproducible isolation of bacterial N‑linked
glycopeptides, modified with nonsialylated
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nonprotein glycan discovery
Detection of bacterial glycolipids by MS

Technological advancements in genomics, transcriptomics and proteomics have allowed scientists to probe biological systems with increased
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an absence of accumulating truncated LLO
intermediates, suggesting feedback regulation
of the pathway. This conclusion was supported
by the observation of the accumulation of
UDP-diacetamido-trideoxy-Hex in the galactosyltransferase mutants, pglJ and pglH, and the
observed allosteric regulation in the analogous
yeast oligosaccharyltransferase complex [80] .
Since undecaprenol is in limited abundance in
the bacterial cell and is involved in a plethora of
cellular activities, some of which are vital for cell
survival, it is not surprising that a feedback regulation of the Pgl pathway would exist to prevent
the accumulation of LLOs and sequestering of
undecaprenol from other biological processes.
The application of affinity capture-MS to the
analysis of membrane-associated processes in
carbohydrate biosynthesis pathways provides a
simple and rapid method to gather structural
information for the oligosaccharides under
study. Unlike conventional techniques, radioisotope labeling and chromatographic separation
are not required for analysis [81] . In addition, by
varying the lectin used for affinity capture, this
method can be applied to a wide range of systems. Analysis of complex bacterial carbohydrate
biosynthetic pathways, such as those for pilin
O‑glycosylation and peptidoglycan assembly,
may provide new insights into the synthesis and
control of these glycans. Targeted glycolipidomic
profiling is a powerful tool for bacterial glycobiology. It provides a high-throughput method
for assessing the role of genes in a biosynthetic
pathway and allows for the identification of
potential regulatory mechanisms, by detecting
the accumulation or absence of intermediates in
the pathway. With the recent advances in glycoengineering in bacteria, affinity-capture CE–MS
also allows for a more comprehensive assessment of the efficiency and potential bottlenecks
associated with producing potential protein
glycoconjugates in bacteria. Current work on
the analysis of bacterial LLOs is focused on the
development of more general and nonselective
enrichment procedures.

of

precision and sensitivity. While the analysis of
lipids from microorganisms has been around
since the 1950s, the tools for the examination
of the lipidome and, in particular, the glycolipidome are still emerging [68–70] . The role of
glycolipids in host–pathogen interactions is
an emerging field, with the bulk of the scientific literature revolving around the analysis of
lipid A [71,72] . Traditional methods for the ana
lysis of lipid-linked oligosaccharides (LLOs),
a subclass of biologically relevant glycolipids,
usually involves chemical or radioactive labeling of the oligosaccharide component followed
by chromatographic or electrophoretic separation [73] . In the realm of bacterial glycolipidomics, there is an increasing body of work on
the assembly of bacterial polysaccharides and
the polyisoprenyl carriers upon which they are
assembled. MS has been the tool of choice to
investigate the levels of undecaprenyl phosphate
in bacterial membranes [74] , levels of lipid II, an
intermediate in peptidoglycan biosynthesis [75] ,
and levels of polyisoprene intermediates in LPS
biosynthesis in Salmonella spp., E. coli and
Francisella novicida [76–78] . While glycolipidomics is still an emerging field, the C. jejuni Pgl
pathway (described in detail previously) will be
used as an example of the information that can
be obtained by analyzing lipid-mediated steps in
oligosaccharide biosynthesis in vivo.
Lipooligosaccharide profiling of the Pgl pathway using the newly developed affinity-capture
CE-MS has provided unique insight into the
synthesis of the N‑glycan oligosaccharide [79] .
This method has allowed for the rapid enrichment of LLOs, utilizing an immobilized lectin
(soybean agglutinin) with specificity towards the
GalNAc residues in the C. jejuni LLO of interest. In order to characterize the membrane-associated steps in the Pgl pathway, both wild-type
C. jejuni and isogenic mutants of the pathway
were used to investigate the assembly of LLO
intermediates. Analyses of isogenic mutants in
the oligosaccharyltransferase (pglB) and membrane flippase (pglK ) revealed an accumulation
of undecaprenyl-pyrophosphate (Und-PP) heptasaccharide, with a significantly greater amount
found in the flippase mutant. The lower levels
of Und‑PP-heptasaccharide in the pglB mutant
is most likely due to the presence of enzymes
in the periplasm responsible for the recycling
of Und-PP. The accumulation of LLO intermediates in these mutants confirmed that the
C. jejuni N‑glycan is assembled on undecaprenyl phosphate. Analysis of isogenic mutants
in steps upstream of the flippase PglK revealed

A

ut

ho

rP

ro

Review

6

Future Microbiol. (2010) 5(2)

LPS profiling by CE–MS

Capillary electrophoresis is a high-resolution
technique for the separation of complex biological mixtures [82] . When coupled with MS, CE
provides a powerful approach for the identification and structural characterization of analytes.
This technique has been used for the characterization of bacterial glycolipids and glycoconjugates from bacteria, including H. influenzae
[83–87] , Neisseria meningitidis [85,88] , Pasteurella
future science group
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virulence afforded by LPS sialylation depends
on the ability of NTHi to scavenge sialic acid
from the host [110] . Further work on NTHi LPS
glycoforms followed changes in LPS up to 7 days
postchallenge in the chinchilla and constituted
the first detailed description of LPS glycan
patterns during the course of a bacterial infection [115] . Over the course of the study, a trend
toward less-complex glycoforms was observed
as the infection progressed. It was suggested
that the organisms responsible for maintaining
active infection may undergo major changes in
their metabolic profile as a consequence of available nutrients and their response to the stresses
mediated by the host’s plethora of innate and
acquired immune responses [112] . The biosynthesis of shortened LPS glycoforms may represent a
metabolic consequence or an adaptive response
to limited energy resources available within the
host environment [115] . The role of the in vivo
LPS O-antigen in pathogenesis is not clear, but
it is interesting that the LPS carbohydrate structure is influenced by the host environment. This
underlines the importance of further studies of
LPS and other glycans from bacteria grown
within the host environment.
One drawback to LPS analysis by CE–MS
is the limitations posed by the buffer used in
CE separation, and the deleterious effects it can
have on detection limits. Gas-phase ion mobility separations have the potential to separate
glycan structural isomers, based upon their
3D shape [116,117] . High-field asymmetric waveform ion mobility spectrometry (FAIMS) is a
gas-phase ion separation technique based on
compound-dependent differences in ion mobility at high field [118,119] . The FAIMS system acts
as an ion filter which continuously transmits a
selected type of ion, independent of mass-tocharge ratio. This allows users to selectively isolate target ions based upon physical properties.
The approach also reduces chemical background
and other interferences in MS spectra. FAIMS is
increasingly being combined with front end LC
or CE separations. The coupling of a FAIMS to
a CE–MS system was successful in separation
of trace levels of LPS oligosaccharide glycoforms
from NTHi [83] . It was found that the signal of
interest was increased as many as 7.5-fold when
the FAIMS device was used [83] .
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multocida [89–91] , H. pylori [92,93] , C. jejuni
[94–96] , Vibrio anguillarum [97] and Aeromonas
salmonicida [98] . CE–MS has been widely used
for characterizing differences in LPS glycoform
and phosphorylated populations [84,88,99] . This
is achieved by exploiting differences in the
molecular conformations and charge distributions of closely related LPS molecules during
electrophoretic separations.
A recent study employed immunoaffinity capture CE–MS to investigate LPS changes in the
fish pathogen A. salmonicida under co-culture
conditions [100] . When co-cultured with trout
macrophages in intraperitoneal chambers, significant differences were observed in the mass spectral fragmentation patterns of the LPS O‑chain
polysaccharide isolated in vivo. The O‑antigen
repeating unit was previously reported to contain
a rhamnose residue substituted with side chain
glucose and O‑acetyl group [101] . Compared with
LPS isolated from cells grown in vitro, glycoforms
containing multiple glucose residues and O‑acetyl
groups were observed in the in vivo samples.
Lipopolysaccharide is implicated as a major
virulence factor of H. influenzae. Nontypeable
H. influenzae (NTHi) is a significant cause of
otitis media in children, and is the most common pathogen recovered from the middle ear of
children with recurrent episodes [102] . Although
immunity against NTHi appears to develop
after acute otitis media, protection is strainspecific, permitting recurrent episodes owing to
antigenically distinct isolates. Extensive structural studies of LPS from H. influenzae have led
to the identification of a conserved glucose-substituted triheptosyl inner-core linked to lipid A
[103–109] . The LPS of H. influenzae mimics host
glycolipids and possesses several phase-variable
modifications, which allow the bacterium to
evade the host immune system. Recent work
has shown that NTHi LPS oligosaccharides
replaced by terminal sialic acid (N‑acetyl neuraminic acid) residues are critical virulence
factors in the pathogenesis of otitis media in
chinchillas [110] and gerbils. In the chinchilla,
sialyation of LPS modifies the interaction with
complement [111] . This altered recognition
could be attributed to sialylation masking the
LPS epitopes recognized by complement [111] or
molecular mimicry of host-like structures [110] .
It has also been proposed that the expression
of sialylated LPS glycoforms may play a role in
pathogenesis by promoting biofilm formation
[112–114] . One study, using a CE electrospray ionization MS (CE–ESIMS) technique on NTHi
isolated from chinchilla, suggested that the
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Bioinformatics for glycomics

The development and use of informatics tools
and databases for glycobiology and glycomics
research has increased considerably in recent
years. However, the general development in
www.futuremedicine.com
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the integrated interfaces of diverse datasets in
the CFG’s relational databases, which contain
information regarding glycan-binding proteins,
glycan structures and associated glycosyltransferases. The Kyoto Encyclopedia of Genes and
Genomes database (KEGG) have produced an
extension, KEGG Glycan, which is managed and
developed by the Kyoto Unversity Bioinformatics
Center (Kyoto, Japan). Glycosciences.de is maintained by the German Cancer Research Center
(Heidelberg, Germany) and provides researchers
with MS and glycan structure data, as well as
applications for glycan analysis. Although the
three current databases share the same initial
collection of glycan structure, they use different
file formats, which, in proteomics and glycoproteomics alike, is a huge informatics stumbling
block. GlycoVault is a web-based informatics
gateway that contains databases, ontologies and
other glycan structure-related data. This application also contains the Glycomics Browser, a webbased visualization and analysis tool for glycan
data. The use of these databases in the analysis
of bacterial glycomes will rely upon the continued accumulation of bacterial glycan structural
information. For further information, readers are
directed to an excellent recent tutorial article [128] .
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this field can still be considered as being in its
infancy, when compared with the bioinformatics
tools available to the genomics and proteomics
communities. For example, the automated identification of peptides in proteomics studies is
becoming almost routine, with the use of tools
such as Mascot [301] . The major factor hindering
the development of equivalent tools for glycoproteomics and glycomics is the lack of automated
tools that can retrieve structural information
from MS data. This challenge is compounded
by the structural diversity of glycans and the
variety of methods required to characterize both
glycopeptides and the modifying glycan. The
development of library-based glycan sequencing tools are slowed by the lack of well-curated
collections of glycan sequences.
Presently, MS-based glycan and glycopeptide analysis is generally restricted to specialist
laboratories that posses the expertise required
for manual interpretation of glycan-containing
spectra. Even for trained mass spectrometrists,
analysis of multiple glycan MS or MS/MS spectra frequently becomes the bottleneck in data
analysis. In many cases, manual annotation
can be resource limiting or even prohibitive
for a high-throughput glycomics screen. Tools
are being developed to address issues in glycan
profiling, particularly the recent development
of an algorithm called Cartoonist, which performs automated annotation of MALDI-TOF
spectra [120] . This works with single MS spectra
to determine the composition of a particular
glycan structure. Cartoonist assigns plausible
glycan structures and provides a confidence level
assignment to aid further analysis. The graphical forms consist of the spectra annotated with
either cartoons of the structures in symbol form,
or with formulas of each monosaccharide.
Other algorithms and tools for either glycan
structure prediction or glycan annotation also
exist. For example, the GLYCH method was
developed for the interpretation of MS data, to
list all possible fragment types of glycans [121] .
Other online tools for annotating glycan structures from mass peaks include GlycoPep ID [122] ,
Glyco-Mod [123] and GlycoPeakFinder [124] .
In addition to interpretation tools, there are
currently three major databases that house
glycan structure data: KEGG Glycan [125] ,
Glycosciences.de [126] and a relational database hosted by the Consortium for Functional
Glycomics (CFG) [127] , an international initiative funded by the National Institute of
General Medical Sciences (MD, USA). The
CFG’s database is a web portal connected to
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Application of NMR to
bacterial glycomics

Nuclear magnetic resonance, in particular liquid
state NMR, has been employed to study microbial metabolism for more than 30 years [129] , and
has played a critical role in the determination of
the structure of a myriad of microbial glycoconjugates. NMR has been fundamental for the structural analysis of CPS and LPS from numerous
microbial pathogens [130–138] . While NMR has
provided detailed information regarding the biomimicry of these molecules, this review will focus
on the application of whole-cell and solid-state
NMR to the elucidation of the pathogen glycome.
HR‑MAS whole-cell NMR

High-resolution magic angle spinning NMR
(HR‑MAS NMR) was initially developed in
the late 1990s and has been used to characterize a variety of biological samples [139,140] .
In HR‑MAS NMR, the sample is spun at the
magic angle of 54.7° in order to reduce spectral line broadening caused by chemical shift
anisotropy and contributions from magnetic
susceptibility [141,142] , making this technique
amenable to the acquisition of high-resolution
spectra from various biological matrices, including intact bacterial cells. The majority of the
future science group
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literature on HR‑MAS whole-cell NMR has
focused on the CPS of Gram-negative pathogens, such as C. jejuni [96] and N. meningitidis
[143] . In recent years, HR‑MAS whole-cell NMR
has been expanded to cell wall components of
mycobacteria, such as arabinogalactan [144] .
High-resolution magic angle spinning NMR
has been used extensively to study the CPS and
the N‑linked Pgl pathway (described previously)
in the intestinal pathogen C. jejuni [40,145,146] .
The CPSs produced by C. jejuni are important
virulence factors involved in colonization and
invasion and are the major antigenic component of Penner’s serotyping system [147] . To date,
there have been several C. jejuni CPS structures
reported that identify a number of phase-variable
structural variations, such as the incorporation
of methyl, ethanolamine and aminoglycerol
groups on the CPS sugars [148,149] . One of the
more unusual modifications reported is the
O‑methyl phosphoramidate CH3OP(O)(NH2)
(OR) (MeOPN) group – a labile, phase-variable
phosphorylated structure. HR‑MAS NMR has
been employed as a rapid, high-throughput
means to directly examine animal and human
isolates from diverse clinical presentations and
geographical locations for the presentation of
the MeOPN CPS modification [150] . An interesting aspect of this study by McNally et al. was
the application of HR‑MAS whole-cell NMR
to examine MeOPN expression within an avian
host [150] , providing evidence that this phasevariable modification is present during colonization of the GI tract (Figure 3) . In addition, this
technique was used to demonstrate the commonality of this phase-variable modification in 61 of
111 strains tested. Through the combination of
bioinformatic analysis of the C. jejuni genome,
mutagenesis and whole-cell NMR, the authors
were able to identify the genes responsible for the
biosynthesis of this unique modification. The
applicability of HR‑MAS whole-cell NMR as
a high-throughput screen for identifying genes
involved in the biosynthesis of surface polysaccharides is further illustrated by the identification of the genes responsible for d-glycero-lglucoheptose biosynthesis in C. jejuni 11168
CPS [145] .
The applicability of HR‑MAS NMR is not
restricted solely to the analysis of surface polysaccharides. It has also served to elucidate the
N‑linked Pgl pathway in C. jejuni 11168 [96] .
Through the use of a CPS-negative strain, whose
signals interfere with the detection of N‑glycan
signals, the anomeric signals of the N‑glycan
heptasaccharide were observed in vivo. This
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Figure 3. High-resolution magic angle spinning nuclear magnetic resonance
analysis of the cecal contents of a representative Campylobacter jejuni
colonized chick. (A) High-resolution magic angle spinning (HR-MAS) 1H nuclear
magnetic resonance (NMR) spectrum of plate-grown 11168H cells (256 scans). The
inset shows the spectrum for the same sample analyzed with a 1H-31P heteronuclear
single quantum coherence HR-MAS NMR experiment (1024 scans, 31P decoupled,
1
JH,P = 12 Hz). (B) The HR-MAS 1H NMR spectrum of the cecal contents of a chick
that has been colonized with C. jejuni 11168H at 48 h post-inoculation (256 scans).
The inset shows the spectrum for the same cecal sample examined using the 1H-31P
heteronuclear single quantum coherence HR-MAS NMR experiment (1024 scans).
OMe is the –OCH3 group located at C-6 of residue (F) and HOD is the deuterated
water resonance. All spectra were acquired at 500 MHz (1H). The labeling of
resonances (C–E) correspond to the anomeric signals of the monosaccharides in
the 11168H capsular polysaccharide structure presented at the bottom.
Reproduced with modifications from [150] .
MeOPN: O‑methyl phosphoramidate.
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the arabinogalactan core, suggesting that EMB
inhibits multiple enzymes in the arabinan biosynthetic pathway, but not the arabinosyltransferase, which builds the 5´-linked core [144] . This
approach allows for the observation of the effects
of drug treatment and gene mutation on the cell
wall, which could help in defining mechanisms
of action for other cell wall inhibitors, and the
screening of new cell wall-acting drugs. It will
be interesting to see if this methodology can
be applied to the elucidation of the role of the
mycobacterial cell wall in host cell interactions.
Solid-state NMR of peptidoglycan

Another component of the bacterial glycome
that can sometimes be overlooked owing to its
inherent heterogeneity and insolubility is peptidoglycan. With peptidoglycan serving as a major
structural component of the bacterial cell, studying the biosynthesis, metabolism and dynamics
of this critical structure by traditional techniques
can be difficult. While advances have been made
in the characterization of peptidoglycan-acting
enzymes with their peptidoglycan substrates
[153,154] , these are in vitro techniques that cannot begin to dissect the complex interactions
that occur with such a heterogeneous substrate.
In addition, peptidoglycan biosynthesis and
metabolism has traditionally been a well-spring
of antimicrobial targets, and still holds vast
potential for the development of new antimicrobials. Recent applications of solid-state NMR
to the study of the dynamics and structure of the
Gram-positive cell wall demonstrate the potential of this technique for studying peptidoglycan
dynamics in vivo [155] , as well as for dissecting
the mode of action and binding specificity of cell
wall-acting antibiotics [156–161] .
To date, solid-state NMR of Gram-positive
cell walls has predominantly focused on the
analysis of the stem peptide and pentapeptide bridges linking adjacent glycan strands in
Staphylococcus aureus [155] . Through the use of
13
C- and 15N‑labeled amino acids typically found
in the peptidoglycan stem peptide, a quantitative
measurement of the degree of cross-linking could
be obtained in intact S. aureus cells. Traditional
methods for analysis of peptidoglycan crosslinking usually involve enzymatic digestion
and analysis of muropeptides by HPLC or MS
[162] . The use of solid-state NMR and labeling
experiments provided information regarding
the tertiary structure of the peptidoglycan sacculus [163] . Spin diffusion experiments can be
used as a molecular ruler to measure the distance
between the glycan backbone and stem peptide,
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provided the capacity to quantify the levels of
N‑glycan heptasaccharide in isogenic mutants
of the Pgl pathway, and assess the ability of the
oligosaccharyl transferase PglB to transfer truncated glycans. It should be noted that the ability to observe the N‑linked glycan by HR‑MAS
NMR is most likely due to the production of
protein-free heptasaccharide in the periplasm,
resulting from competition between the transfer
of the lipid-linked heptasaccharide to protein,
and hydrolysis by water [61] .
While the vast majority of applications of
HR‑MAS NMR to glycomics have utilized
C. jejuni, there have been several applications
of this technique to the study of other microbial
glycomes, particularly in the structural characterization of the cell wall of living mycobacterial cells [144,151] . In these studies, Mycobacterium
smegmatis was used as a model organism for the
pathogen M. tuberculosis in an attempt to elucidate the major carbohydrate components of the
mycobacterial cell wall. The major challenges
in studying the mycobacterial cell wall revolve
around deciphering the cell wall biosynthetic
pathways and its interaction with antimycobacterial drugs and host tissues. From a ‘systems
biology’ viewpoint, identifying how the various
cell wall components interact with each other
could facilitate the development of new anti-TB
drugs and treatment strategies. Lee and coworkers have successfully applied multidimensional
HR‑MAS NMR to the analysis of whole-cell
mycobacteria [144,151] . The use of selective labeling techniques, such as heavy nitrogen (15N) and
carbon (13C) sources has allowed for the resolution of signals from different mycobacterial
macromolecular structures, including mycolyl
arabinogalactan, lipoarabinomannan and glycolipids. Through the use of selective labeling,
the authors were able to measure the levels of
arabinogalactan and lipoarabinomannan in
a semi-quantitative manner, which is a useful
feature when investigating the biosynthetic pathways of these molecules. An interesting feature
of using multidimensional HR‑MAS NMR is
the ability to utilize a whole-systems approach
to study the effects of antibiotics on the mycobacterial cell wall. In the case of M. smegmatis,
the effects of ethambutol (EMB), a first-line
treatment for TB known to reduce the arabinan content of the cell wall through inhibition
of the arabinosyltransferases EmBA–C, were
investigated [152] . HR‑MAS NMR indicated a
significant decrease in most arabinose signals in
the mycobacterial cell wall upon treatment with
EMB, with the exception of the 5´-linked Araf in
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A lack of high-throughput analytical tools for the
characterization of bacterial glycans has been an
obstacle in the examination of the dynamics of
bacterial carbohydrate variation over the course of
infection. Recently, lectin-based microarrays have
been developed as a glycoprofiling tool. This technology exploits many features of more traditional
microarray tools, but with a series of lectins immobilized on a single chip, allowing high-throughput
screening of the entire cellular glycome [180–182] .
Lectins are naturally occurring glycan-binding
proteins [183] . A wide variety of lectins has been
described, each with a unique glycan-binding profile. Some lectins bind to a very specific glycan
structural feature, while others show a wider or
more complex binding profile [184] . The commercial availability of purified lectins has led to their
wide use as a means of detecting glycoproteins
by western blotting, and isolating glycoproteins
and glycopeptides by affinity chromatography.
Lectin arrays have the advantage of requiring
small amounts of samples, from picogram [182] to
microgram quantities [180] , under mild conditions
that potentially allow the detection of secondary
modifications that might be lost under more traditional sample preparation methods. In addition,
this approach does not require glycan release or
purification prior to analysis, nor does it rely upon
costly and complex MS equipment for analysis.
A recent application of lectin microarrays to
the study of E. coli surface glycoconjugates demonstrated that the array was able to differentiate
between 21 closely related strains [185,186] . This
opens the door to rapid carbohydrate-based bacterial fingerprinting [180,182,185,186] . Perhaps more
importantly, the platform allowed dynamic alterations in the E. coli cell surface glycome to be
followed and enables the examination of changes
in the glycome in response to the host over time.
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Sialic acids have been shown to be involved in
many host–pathogen recognition events. As a
result, there has been much activity in the search
for methods to enrich for and identify sialation
in complex tissues [169–172] . Studies have demonstrated that analogues of glycan precursors, for
example azido analogues of sugar precursors,
can succesfully be incorporated in living cells
[171–184] . The resulting azido sugars, expressed
on the cell surface, can then be labeled via reactions such as the Staudinger ligation (commonly
referred to as ‘click chemistry’), functioning as a
bio-orthogonal reporter group [175] . This type of
approach is being exploited for the study of both
eukaryotic and bacterial cells [172] . For example,
the pseudaminic acid (Pse) pathway of C. jejuni
has been targeted using this type of approach. Pse
is a nine-carbon a‑keto acid that is structurally
related to the sialic acids. The sugar is O‑linked
to flagellin proteins in pathogenic bacteria,
such as H. pylori and C. jejuni. Glycosylation is
required for assembly of the flagellar filament,
and has been implicated in the virulence of these
bacteria [176] .
In a recent report, Liu and coworkers synthesized a neutral azido sugar precursor that was
taken up by C. jejuni cells and converted into
an azido-labeled Pse derivative in vivo [177] . The
third intermediate in the Pse pathway, 6-deoxyAltdiNAc, was targeted for the introduction of

Lectin microarrays: the potential
for dynamic studies of the
bacterial glycome

ro

Probing the bacterial glycome using
chemical & physical methods
Chemical labeling: bioengineering of
bacterial glycans

the labeled analogue, 6-deoxy-Alt-NAc4NAz,
based on synthetic considerations. The analogue
was incorporated into the growth medium,
where it competed readily with the natural substrate and was tolerated by downstream steps
in the Pse pathway. The bacteria harboring the
azido-labeled Pse were motile and the azido
functionality was maintained after in vivo incorporation into flagella. While the use of these
tags in glycomic imaging experiments has been
reported for eukaryotic systems [178,179] , applications for these modified glycans in bacteria have
yet to be demonstrated.

rP

which provided information on the orientation
of peptidoglycan strands in the Gram-positive
cell wall. The results obtained from these experiments bring into question the traditional view
of Gram-positive cell wall architecture. The
commonly held view is that the glycan backbone adopts a helical twist so that the stem peptides within a plane perpendicular to the glycan
main chain are antiparallel [162,164,165] . The use
of solid-state NMR and spin diffusion studies
seems to suggest that the stem peptides can be
antiparallel as well [166] . This in vivo analysis
of peptidoglycan provides relevant data on the
organization of this essential bacterial polysaccharide under physiologically relevant conditions. Solid-state NMR provides a powerful tool
to assess the interaction of potential antimicrobial candidates developed to target the bacterial
cell wall [158,159,166–168] and provides direction in
the refinement of activity or target specificity for
medicinal chemists.

Review

future science group

www.futuremedicine.com

11

Reid, Fulton & Twine

The outermost glycoconjugate expressed
on the cell surface of C. jejuni is the CPS, the
major serodeterminant of the Penner serotyping scheme [147] . Genomic analysis of C. jejuni
isolates indicates a high degree of genetic diversity in the CPS gene clusters, resulting in a large
array of CPS structures and modifications being
expressed. Bacterial capsules have long been
thought to play a protective role against adverse
conditions that bacteria might encounter, either
within the host or the environment [195] . The
C. jejuni CPS is involved in bacterial adherence
and colonization of host tissues, protection of
the bacterium from dessication and impairment
of phagocytosis or complement mediated killing [146] . CPS structures from several different
C. jejuni isolates were determined using solution NMR and, as mentioned earlier, HR‑MAS
NMR. These studies have illustrated the diversity of this cell surface polysaccharide [148–150,196] .
Overall, there is still much to be learned about
the role of the CPS in C. jejuni, with regards to
host interactions.
The outer membrane of C. jejuni is composed
of a phase-variable LOS, which mimics several
human ganglioside structures [197] . This molecular mimicry in some patients is thought to lead to
the development of the autoimmune neuropathies
Guillain–Barré syndrome and/or Miller Fisher
syndrome, caused by the host immune response
to LOS ganglioside mimics that have cross-reactivity with host glycolipids [198] . C. jejuni can
vary LOS biosynthesis genes through homopolymeric tract variation, which occurs with a
relatively high frequency. LOS diversity can vary
owing to environmental pressures, allowing the
pathogen to adapt and survive in a variety of
environments inside and outside the host. Early
work on this glycoconjugate supports a role for
LOS in cellular adherence and invasion [199] . The
application of analytical methods with increased
sensitivity has recently allowed a more detailed
analysis of the structural diversity of C. jejuni
LOS. Sialic acid moieties within LOS have been
demonstrated to be O‑acetylated, while heptoses
have been observed to harbor O‑linked glycine
modifications [200,201] . The biological role of this
additional level of LOS glycan diversity remains
to be elucidated.
Whole-genome comparisons of 111 strains
of C. jejuni, using comparative phylogenomics,
demonstrated that isolates from a variety of hosts
fell into two clades, defined as livestock and nonlivestock [202] . Of the genes identified as significantly prevalent in either clade, six genes within
the O‑linked flagellin glycosylation biosynthetic
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While this study highlights the promise of the
technology, there are some limitations in its use
for bacterial studies. Since whole bacteria were
screened, only accessible carbohydrate motifs on
the cell surface were visualized, rather than the
whole bacterial glycome. However, as the authors
acknowledge, it is probable that the surfaceaccessible carbohydrates are those most likely to
be involved in immune recognition and cell adhesion [185,186] . Perhaps more importantly, the lack
of lectins that recognize sugars unique to bacteria
is a significant limitation to this technique. The
above study used a group of lectins with wellcharacterized binding to mammalian carbohydrate epitopes, which are also found on bacterial
pathogens known to express mammalian-like
glycans [184,185,187–190] . Lectin microarrays have
the advantage of parallel analyses by many lectins simultaneously, but suffer the disadvantage
that they are limited by a panel of approximately
60 existing commercially available lectins. These
lectins suffer unexpected cross reactivities and
often their interaction with bacterial glycans
cannot be predicted [186,191] . This is in addition
to potential problems, such as linking chemistry
and the impact of lectin orientation upon binding. In this regard, alternatives to the use of lectins are being sought, including nonprotein carbohydrate binding moieties or short peptides that
might function as lectin analogues [192] . As the
repertoire of well-characterized bacterial glycanbinding proteins increases, the applications of lectin binding will likely be expanded and applied
to screen the surface glycomes of other bacteria.
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Campylobacter jejuni, a Gram-negative intestinal
food-borne pathogen, is a major cause of human
gastroenteritis and can be associated with the
postinfectious neuropathy Guillain–Barré
syndrome [193] . Transmission of C. jejuni predominantly occurs through consumption of
contaminated meat products, in particular
poultry. Genome sequencing provided evidence
of an unexpected capacity for this organism to
produce a wide range of glycoconjugates, including LOS, CPS and proteins modified with N‑
or O‑linked sugars [194] . Glycobiologists have
focused their efforts on C. jejuni as a toolbox
for understanding bacterial glycan biosynthetic
pathways. A wealth of information on the role
of these glycoconjugates in pathogenesis exists
in the literature, which makes C. jejuni a model
organism for the discussion of the role of the
glycome in host–pathogen interactions.
Future Microbiol. (2010) 5(2)
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that the pathogen forms biofilms in vivo. In this
regard, a recent study investigated the role of
the O‑linked glycosylation locus in chicken
colonization. In particular, the gene Cj1324
was shown to be involved in the biosynthesis of
novel legionaminic acid derivatives on flagellin
of C. jejuni 11168H. These modifications altered
AAG, cell charge and the ability of the mutant
strain to colonize chickens [62] . Studies in these
animal models point to a role of flagellin, and flagellin glycosylation, in colonization and disease.
As with many studies of bacterial glycomes, the
details of pathogen glycan interactions with cells
of the host have yet to be explained.
As discussed previously, Campylobacter possesses an N‑linked protein glycosylation system,
found within a 16 kB region of the genome [39,42] .
Addition of the N‑linked glycan occurs within
the perisplasm, with an estimated 150 periplasmic proteins harboring the target sequence
for glycosylation (so-called N‑linked sequon).
Several glycoproteins were identified in early
work – Cj1594c, PEB3 and Campylobacter glycoprotein A (CgpA). Glycoproteomic analyses by
2D gels showed the glycosylation of both PEB3
and CgpA to be dependent upon the presence
of a functional PglB protein [207] . Since then,
an increasing number of N‑linked glycoproteins
have been identified, contributing to the total
C. jejuni glycome. These include VirB10, a component of the type IV secretion system, and an
inner membrane lipoprotein, CjA [208] .
Discerning the role the N‑linked heptasaccharide plays in pathogenesis is challenging.
The variety of proteins that are modified would
suggest that any mutation that disrupts the pgl
pathway will have multiple pleiotropic effects.
Indeed, disruption of the pgl biosynthetic pathway results in bacteria that have a diminished
capacity to adhere to and invade human intestinal cells (INT407) in vitro and a reduced ability to colonize chickens [205,209–211] . Given the
number of glycosylated proteins, attributing a
direct role for N‑linked protein glycosylation in
colonization and invasion is tenuous at best. Its
role may be more general, and may be related
to aspects such as protein stability, protection
against proteolytic degradation and promoting
specific protein–protein interactions [212,213] .
This view is supported by the observation that
the N‑glycosylated VirB10 is less stable when
not glycosylated [214] . Loss of N‑glycosylation
appears to affect other bacterial processes, such
as iron acquisition [215] , amino acid transport and
biosynthesis and O‑linked flagellin glycosylation
[214] . As mentioned above, these observations
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locus were of particular interest. The strain
NCTC11168, found in the livestock clade, has
a greater number of putative flagellin-associated biosynthetic genes (50) compared with a
sequenced human isolate, 81–176 (26 genes) [33] .
This would suggest that livestock-associated
strains have the potential to elaborate more complex flagellin modifications in comparison with
strains within the nonlivestock clade. However,
the structure of the flagellin glycan of livestock
strains is not known. The structure of the flagellin glycan from C. jejuni 81–176 is known and
is perhaps one of the most well-studied flagellin glycosylation systems. Flagellin structural
proteins, FlaA and FlaB, are decorated with the
nine-carbon Pse sugar (5,7-diacetamido-3,5,7,9tetradeoxy-l-glycero-a-l-manno-nonulosonic
acid [Pse5Ac7Ac], as well as an acetamidino
form 5-acetamido-7-acetamidino-3,5,7,9-tetradeoxy-l-glycero-a-l-manno-nonulosonic acid
[Pse5Ac7Am]). Derivatives of these sugars have
also been identified in strains of C. jejuni and
contribute to the structural variability of flagellin
glycosylation [65,66,203,204] . In C. jejuni 81–176,
glycosylation of flagellin is required for flagellar
filament biogenesis and bacterial motility and,
therefore, has biological significance [33] . The
sites of glycan modification of flagellin are predicted to be surface exposed in the fully folded
protein, pointing to a role in surface interactions,
either with the host cells or other bacterial cells.
Autoagglutination (AAG), a known marker of
virulence in some bacterial pathogens, including
C. jejuni, has been shown to be dependent upon
flagellin glycosylation [33] . Studies of defined
mutants, deficient in various glycan-associated
biosynthetic genes, pointed to a role for both
Pse and PseAM in AAG. A further study of a
C. jejuni 81–176 PseA mutant, which only modifies flagellin with a single sugar, Pse5Ac7Ac, demonstrated altered AAG compared with wild-type
strains. Interestingly, the mutant exhibited alterations in its ability to adhere to a human intestinal epithelial cell line (INT407 cells). During
shorter incubation times, only minor defects were
observed but, as incubation times were extended,
wild-type cells formed microcolonies apparently
interacting via flagellar filaments. By contrast,
the PseA mutant adhered as single cells, with
no visible microcolony formation [33,205] . In an
in vivo study using the ferret diarrheal model of
disease, the pseA mutant was attenuated relative
to the wild-type C. jejuni. Although microcolony
formation is the first step in the formation of
bacterial biofilms, and C. jejuni has been shown
to form biofilms in vitro [206] , there is no evidence
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could be due to secondary effects. Beyond the
ambiguous role of the Pgl glycosylation system in
bacterial virulence, studies have opened the door
towards the use of this pathway in glycoengineering. This is made possible due to the observation that the entire pgl locus can be functionally
transferred into E. coli [39] and the fact that the
oligosaccharyltransferase PglB to possess relaxed
specificity for the donor glycan [43] .
Future perspective
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Despite the growing awareness of the biological
significance of bacterial glycoconjugate structures, the study of bacterial glycomics is still
in its infancy. Neither the role of bacterial glycans in virulence nor the impact of the bacterial glycome in host–pathogen interactions is
clear. Many studies have instead focused upon
the eukaryotic host carbohydrates to which
many bacterial pathogens bind. As such, there
is a pressing need for the adaptation of methods
and bioinformatic tools designed for eukaryotic
glycomic studies to the study of bacterial glycans. For example, eukaryotic glycan libraries
are already being created for use in large-scale
studies of carbohydrates. In addition to the traditional, albeit complicated, chemical methods,
there are now chemoenzymatic approaches being
employed that take advantage of known glycosyltransferases [216] . This sort of technology needs
to be adapted for the production of bacterial glycans on a large scale. However, this progress is,
and will likely continue to be, hindered by the
fact that microbes tend to produce such diverse,
unique and unusual sugar modifications.
Although in vitro studies are important for
the dissection and study of individual glycans,
there will need to be a shift towards increased
in vivo work, as the field of bacterial glycomics
continues to grow. It is only through the integration of both in vitro and in vivo studies that
we will begin to fully understand the biological
role and significance of bacterial glycans on a
molecular level, particularly with respect to the
interplay between pathogens and their hosts.
The dynamic nature of the bacterial glycome
should also be investigated by future in vivo
research, directed at determining how the glycome changes over the course of infection and
is impacted by conditions within a host. There
is already preliminary evidence that LPS glycoforms of NTHi become shorter and less complex
over the course of infection, possibly owing to
environmental stresses such as the host’s immune
response or as a result of depleted nutrients [112] .
This may be the most challenging task faced by

bacterial glycomics, as it is in proteomics as well,
owing to the inherent difficulties associated with
studying bacteria grown within a host.
A full understanding of the complex relationship between a pathogen and its host does not lie
in a single field of study. Despite its significance,
glycomics alone will not provide a complete picture. The potential exists for future systems-level
analyses through the incorporation of continued
advancements in other fields, such as genomics, proteomics, transcriptomics, lipidomics and
metabolomics with the ever-growing field of glycomics. In particular, advancements in genome
sequencing technologies will certainly improve
understanding of the genetic basis of glycosylation.
Furthermore, metabolomic-based studies of lipidlinked intermediates of glycoconjugate molecules
will help in the elucidation of their biosynthetic
pathways. Only through such multidisciplinary
collaboration will a complete understanding of
host–pathogen interactions be possible.
As the field of pathogen glycomics continues to grow, there will be significant potential
for diagnostic and therapeutic applications.
Glycoengineering, in particular, offers a number of medically relevant opportunities based
on bacterial glycomic research. This technology
has the capacity to produce humanized glycoprotein therapeutics and to alter protein-associated
carbohydrates to improve both the activity and
half-life of these therapeutic proteins [217] . With
advances in glycoengineering, the large-scale
production of recombinant glycoconjugate antigens for use in the diagnosis of infection and
vaccination against known pathogens will also
be possible [218,219] . In addition to glycoengineering, inhibitors designed to disrupt the biosynthetic pathways of glycan moieties shown to be
involved in pathogen virulence may offer alternative treatment options to antibiotics. This is
particularly important given the ever-growing
issue of antibiotic resistance.
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Executive summary
Mass spectrometry of the bacterial glycome
n

Mass spectrometry is a pivotal technology in glycomics studies.

Analysis of bacterial glycoproteins
n
n

n
n
n

n

n
n

There are increasing numbers of reports of bacterial glycosylation in pathogenic bacteria.
Discovery of bacterial glycoproteins can be challenging due to the diversity of glycans bacteria use to modify proteins.
To date, well-characterized bacterial glycoproteins include pilins, flagellin and other surface-associated proteins of both Gram-negative
and Gram-positive bacteria.
Single proteins, isolated by gel electrophoresis or purification, can be analyzed at the protein or peptide level.
At the protein level, so-called ‘top-down’ mass spectrometry studies of intact protein can rapidly characterize bacterial glycan ions.
At the peptide level, interpretation of individual bacterial glycopeptide tandem mass spectra can be challenging, owing to the diverse
range of bacterial glycans produced.
A combination of mass spectrometry and nuclear magnetic resonance (NMR) over many years has been used to increase our
knowledge of the structures of glycans that form the bacterial glycoproteome.
Reports of methods to specifically isolate bacterial glycopeptides are advancing knowledge of bacterial glycoproteomes.
Metabolomics studies offer an alternative approach to study N‑ or O‑linked protein glycosylation biosynthetic pathways.

of

n

Application of NMR to bacterial glycomics

n

ro

n

High-resolution magic angle spinning (HR-MAS) NMR is a powerful tool for the screening of bacterial capsular polysaccharides, and a
high-throughput method for identifying genes that assemble or modify bacterial carbohydrates.
The application of HR‑MAS NMR to the analysis of the mycobacterial cell wall provides a valuable tool for studying the biosynthesis of
the various carbohydrate components of this highly complex structure.
Solid-state NMR is one of the only methods to study peptidoglycan tertiary structure, as this insoluble, heterogeneous bacterial polymer
is not amenable to classical structrural analytical techniques, such as x-ray crystallography. The ability to study cell wall drug interactions
using this technique will provide valuable information towards the development of new or modified antimicrobials.

rP

n

Probing the bacterial glycome using chemical & physical methods

n
n

n

Lectins (carbohydrate-binding proteins) have been used as tools for glycoprofiling, most recently in microarray formats. This is a
high-throughput approach that has the potential to differentiate between bacterial strains, based upon surface carbohydrate profiles.
Lectin microarrays have also been used to characterize the dynamics of the bacterial surface glycome during the course of infection.
The use of lectins in bacterial studies is hindered by a lack of predictable lectin binding to bacterial sugars. Lectins also suffer from
sometimes unpredictable cross reactivities.
Incorporation of sugar analogues into eukaryotic glycans has been achieved and exploited for imaging the glycome. Metabolic labeling
of Campylobacter jejuni flagellin glycan was carried out using an azido-labeled pseudaminic acid precursor. This could be exploited in
the future for labeling for imaging and other purposes.

ho

n

n

n
n
n

Possibly the best characterized bacterial glycome is that of Campylobacter. This bacterium devotes a considerable proportion of its
genome to carbohydrate biosynthesis.
Studies typically generate deletions of individual glycan-associated biosynthetic genes, and monitor the impact upon glycan structure
and bacterial virulence in model systems.
Components of the C. jejuni glycome have a key role in the interaction with the host, including adherence and biofilm formation.
The molecular targets on host cells with which bacterial glycan interact are largely unknown.
Rapid progress is leading to an increasing number of studies to determine the role of individual bacterial glycans in interactions with
the host.
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